Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
X www.clinicaltrials.gov Once you are on the website, type “NCT03217838”
into the search box and click “Search”.
X www.clinicaltrialsregister.eu Once you are on the website, click “Home and Search”,
then type “2018-003857-73” in the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com Once you are on the website, type “D6130C00003”
into the search box, and click “Find a Study”.
Full Study Title: A Phase I/II, Open-Label, Multicentre 2-Part Study to Assess the Safety,
Tolerability, Pharmacokinetics, and Efficacy of AZD2811 as Monotherapy or in Combination in
Treatment-Naïve or Relapsed/Refractory Acute Myeloid Leukaemia Patients Not Eligible for
Intensive Induction Therapy
AstraZeneca AB Protocol Number: D6130C00003
National Clinical Trials Number: NCT03217838
EudraCT Number: 2018-003857-73
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer
important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0_2022_03_10
12 | Clinical Study Results